May 24 |
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
|
May 22 |
Exact Sciences Earns 2024 Great Place To Work® Certification™
|
May 21 |
Exact Sciences patent infringement case against Geneoscopy to proceed
|
May 21 |
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
|
May 17 |
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
|
May 15 |
Most attractive short-term overwriting stocks for June expiration - Goldman
|
May 11 |
Exact Sciences Corporation (NASDAQ:EXAS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
May 10 |
Exact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net Loss
|
May 10 |
UK NICE backs Exact’s Oncotype cancer genomic test
|
May 10 |
Exact Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|